Core Scientific shareholders have decisively rejected the proposed $9 billion all-stock acquisition offer from CoreWeave, citing concerns over undervaluation amid ongoing AI hype. Meanwhile, CoreWeave proceeded to acquire the AI-focused Python notebook company Marimo as part of its broader strategy to expand its AI infrastructure capabilities.
The rejection came after Core Scientific's largest sharehold...
The rejection came after Core Scientific's largest shareholder, Sina Toussi of Two Seas Capital—a firm specializing in post-bankruptcy investments—recommended voting against the deal. Two Seas Capital criticized the offer as undervaluing Core Scientific, noting that since the deal was announced in July, AI infrastructure investment had accelerated significantly, pushing valuations of Core Scientific’s peers much higher. Toussi argued that the offer, valued at roughly $16.40 per share at the time of the vote, was insufficient given the market momentum and potential growth prospects of Core Scientific itself[1].
CoreWeave, which has transitioned from its crypto mining ori...
CoreWeave, which has transitioned from its crypto mining origins to a leading AI data center operator with significant backing from Nvidia, had initially signed a $10 billion, 12-year contract with Core Scientific to utilize its facilities. The $9 billion acquisition proposal represented a premium over Core Scientific’s trading price at announcement but was ultimately deemed inadequate by key investors[1][4].
CoreWeave CEO Michael Intrator publicly stated that the comp...
CoreWeave CEO Michael Intrator publicly stated that the company would not reconsider or raise its bid, affirming confidence that the offer fairly represented Core Scientific’s value. He emphasized that regardless of the shareholder vote outcome, CoreWeave intended to maintain a strong partnership with Core Scientific[2][3]. The acquisition vote took place on October 30, 2025, with Core Scientific shareholders voting down the deal on October 30[1].
In parallel with the acquisition rejection, CoreWeave announ...
In parallel with the acquisition rejection, CoreWeave announced the purchase of Marimo, a company specializing in Python notebook environments tailored for AI development. This acquisition signifies CoreWeave’s commitment to expanding its AI software ecosystem alongside its hardware infrastructure, aligning with investor enthusiasm around AI workloads and cloud computing services[1].
The dynamics of this deal reflect broader market volatility...
The dynamics of this deal reflect broader market volatility and skepticism amid the AI investment boom. CoreWeave’s stock has surged from a $14 billion to a $66 billion market capitalization since its IPO, fueled by investor interest in AI infrastructure plays. However, Core Scientific shareholders evidently believe their company can capitalize independently on the AI momentum, hoping for better terms or valuation in the future[1][4].
This episode underlines the complexities in mergers and acqu...
This episode underlines the complexities in mergers and acquisitions within fast-evolving sectors like AI, where valuations and strategic visions can diverge sharply between partners despite existing business relationships and contracts. CoreWeave’s acquisition of Marimo suggests it is pursuing growth avenues beyond Core Scientific, even as the larger consolidation plan faces shareholder resistance.
🔄 Updated: 10/31/2025, 7:10:34 PM
Core Scientific shareholders decisively rejected CoreWeave's $1 billion acquisition bid in 2024, citing undervaluation and misalignment with long-term interests, reflecting strong shareholder influence in volatile crypto and AI sectors[1][2][3]. Internationally, the rejection reverberated through global crypto mining and AI infrastructure markets, with CoreWeave, backed by Nvidia and trading on Nasdaq, later announcing a $9 billion all-stock deal to acquire Core Scientific, consolidating 1.3 gigawatts of power capacity and eliminating $10 billion in leases, signaling a strategic vertical integration to meet surging AI demand[5][6]. This move is seen internationally as a major shift towards owning AI and HPC infrastructure, enhancing operational efficiencie
🔄 Updated: 10/31/2025, 7:20:33 PM
Core Scientific shareholders have decisively rejected CoreWeave’s $9 billion acquisition bid, reflecting growing confidence in capturing greater value amid the accelerating AI infrastructure boom. Sina Toussi, Core Scientific’s largest shareholder, criticized the offer as undervalued at $16.40 per share, citing rising peer valuations since the deal announcement in July. Following the rejection, Core Scientific’s market cap surged to $6.6 billion, signaling a reshaped competitive landscape with investors betting on further AI-driven growth beyond CoreWeave’s initial proposal[1].
🔄 Updated: 10/31/2025, 7:30:35 PM
Core Scientific shareholders decisively rejected CoreWeave's $9 billion acquisition bid, driving Core Scientific's stock price up as investors bet on higher AI infrastructure valuations; the company's market cap rose to $6.6 billion following the deal collapse, despite being below CoreWeave's original offer[1]. Largest shareholder Sina Toussi criticized the $16.40 per share offer as a "lowball" amid accelerating AI investments, fueling the stock's rally[1]. Meanwhile, CoreWeave continues its expansion, recently acquiring Marimo, signaling ongoing confidence despite the failed takeover[2].
🔄 Updated: 10/31/2025, 7:40:42 PM
Following news that Core Scientific shareholders rejected CoreWeave’s acquisition bid, Core Scientific’s stock (CRSX) dropped 12% in pre-market trading Friday, closing at $1.38 per share, while CoreWeave’s move to acquire Marimo—a data center infrastructure startup—spurred a 5% surge in its private valuation, now estimated at $18.5 billion, according to Bloomberg sources. Analysts cited market jitters over consolidation in the AI-driven data center sector, with one noting, “Investors are recalibrating risk as CoreWeave pivots to bolt-on deals instead of mega-mergers.”
🔄 Updated: 10/31/2025, 7:50:43 PM
Core Scientific shareholders have rejected the acquisition offer from CoreWeave despite rising AI market excitement, signaling a cautious stance amid the sector’s rapid consolidation[1]. Meanwhile, CoreWeave has accelerated its expansion by acquiring Marimo, reinforcing its aggressive growth strategy in the competitive AI infrastructure landscape[1]. CoreWeave CEO Michael Intrator emphasized that the companies maintain a strong relationship despite the deal setback, indicating potential future collaboration[1].
🔄 Updated: 10/31/2025, 8:00:41 PM
Core Scientific shareholders have formally rejected CoreWeave's acquisition offer despite ongoing AI market enthusiasm, signaling wariness amid the hype. However, CoreWeave CEO Michael Intrator emphasized that the two companies maintain a strong collaborative relationship. Meanwhile, CoreWeave continues its expansion strategy by acquiring Marimo, further fueling its growth in AI infrastructure[1].
🔄 Updated: 10/31/2025, 8:10:41 PM
Core Scientific shareholders decisively rejected CoreWeave’s $9 billion acquisition bid, driven by confidence in further gains amid the AI infrastructure boom. Sina Toussi, Core Scientific's largest shareholder, criticized the $16.40 per share offer as a “lowball” during his opposition campaign, reflecting widespread investor sentiment that valuations are still climbing[1]. This rejection sparked a market rally, pushing Core Scientific’s valuation to $6.6 billion despite staying below CoreWeave’s original offer[1].
🔄 Updated: 10/31/2025, 8:20:40 PM
Core Scientific shareholders have decisively rejected CoreWeave's acquisition offer, reflecting skepticism amid ongoing AI sector hype, according to CoreWeave CEO Michael Intrator on Bloomberg Technology. Despite the snub, Intrator emphasized the companies maintain a strong relationship, while CoreWeave continues its expansion by acquiring Marimo, signaling continued strategic growth independent of the Core Scientific deal[1]. Industry experts view this rejection as a sign that Core Scientific shareholders are cautious about overvalued AI assets amid the current market frenzy.
🔄 Updated: 10/31/2025, 8:30:46 PM
Core Scientific shareholders have rejected the acquisition offer from CoreWeave, reflecting cautious sentiment amid the AI hype, though CoreWeave CEO Michael Intrator emphasized the companies maintain a strong relationship[1]. Meanwhile, CoreWeave continues to expand its market position by acquiring Marimo, signaling aggressive growth despite the setback in merging with Core Scientific[1]. This development reshapes the competitive landscape, as CoreWeave pursues strategic acquisitions to bolster its AI infrastructure capabilities.
🔄 Updated: 10/31/2025, 8:40:48 PM
Core Scientific shareholders decisively rejected CoreWeave's acquisition bid, reflecting skepticism amid the ongoing AI hype despite the industry's buzz. Public reaction appears cautious, with shareholders opting to maintain Core Scientific's independence rather than merging under CoreWeave. Meanwhile, CoreWeave, undeterred, continued its expansion by acquiring Marimo, signaling confidence in its growth strategy beyond the rejected deal[1].
🔄 Updated: 10/31/2025, 8:50:37 PM
Core Scientific shareholders overwhelmingly rejected the CoreWeave acquisition, voting 203.4 million against versus 20.7 million in favor, with nearly 80% turnout of voting power on October 30, 2025, leading to termination of the merger agreement[1]. Despite this setback, CoreWeave is actively expanding its AI infrastructure footprint through acquisitions like Marimo, signaling continued aggressive positioning in the competitive AI compute landscape[2]. This shift highlights CoreWeave’s strategy to grow independently while Core Scientific remains standalone amid evolving market dynamics.
🔄 Updated: 10/31/2025, 9:00:41 PM
Core Scientific shareholders overwhelmingly rejected the CoreWeave acquisition, with 203 million votes against versus 20.7 million in favor, from a total voting power of nearly 80%, leading to termination of the merger agreement on October 30, 2025[1]. Despite this, CoreWeave continues its AI-driven expansion by acquiring Marimo to bolster its cloud infrastructure capabilities, signaling a strategic pivot toward organic growth rather than consolidation[2]. This rejection highlights shareholder skepticism amid AI market hype, potentially increasing Core Scientific’s independent operational risks while CoreWeave accelerates acquisition-driven capacity expansion.
🔄 Updated: 10/31/2025, 9:10:42 PM
Core Scientific shareholders overwhelmingly rejected the proposed acquisition by CoreWeave on October 30, 2025, with 203.45 million votes against versus 20.75 million in favor, representing nearly 80% voter turnout; this resulted in the termination of the merger agreement and a notable decline in Core Scientific’s stock price following the announcement[1]. Despite this setback amid strong AI sector hype, CoreWeave CEO Michael Intrator emphasized in a Bloomberg interview that the companies maintain a strong relationship, as CoreWeave proceeded with its acquisition of Marimo separately[2].
🔄 Updated: 10/31/2025, 9:20:37 PM
Core Scientific shareholders overwhelmingly rejected the $203 million CoreWeave acquisition amid growing AI market hype, with 203.5 million votes against versus 20.7 million in favor, representing nearly 80% of voting shares as of October 30, 2025[1]. Internationally, this move signals cautious investor sentiment in the AI infrastructure sector, tempering expectations for rapid consolidation despite CoreWeave's ongoing aggressive expansion, including its recent purchase of Marimo[2]. CoreWeave CEO Michael Intrator emphasized that the companies maintain a strong relationship, indicating continued global collaboration potential in AI development despite the deal’s failure[2].
🔄 Updated: 10/31/2025, 9:30:38 PM
Core Scientific shareholders have rejected CoreWeave’s acquisition bid, underscoring skepticism about the deal’s value despite soaring AI-driven demand for data centers, with analysts noting that Core Scientific’s stock has surged over 200% in the past year alone. “This rejection signals that investors believe Core Scientific is worth more as a standalone AI infrastructure play,” said Dan Ives, managing director at Wedbush Securities, adding that “the AI gold rush is making legacy mining firms suddenly strategic assets.” Meanwhile, CoreWeave’s simultaneous acquisition of Marimo, a cloud infrastructure startup, for a reported $150 million, highlights its aggressive expansion strategy to capture more of the booming AI compute market.